The debate about heritable human genetic modification continues, with opinions ranging from enthusiasm to dismay, and strong arguments for political as well as scientific involvement. Among the notable contributions in the last few weeks are the following. Jacob Corn, Scientific Director of the Innovative Genomics Initiative (IGI), which is “dedicated to the enhancement and proliferation of genome editing research and technology in both the academic and commercial research communities” in the San Francisco Bay Area wrote a blog post (July 6) that stated categorically:
At this time, the IGI Lab will not do research on human germline editing for several reasons, including: 1. The IGI Lab is focusing on diseases for which somatic (non-heritable) editing would be a transformative advance. … 2. Cas9 technology is currently too nascent for me to consider germline editing wise. …
Corn was an organizer of the Napa meeting that led to the call in Science for a moratorium. CRISPR pioneer Jennifer Doudna is IGI’s Executive Director. Critics may point to the phrase “at this time” as a wiggle or loophole, but he is specifying a moratorium even on research, not just applications. We may not see any stronger statements from major researchers in the field ahead of the National Academies meeting, which Corn says is slated for October.
Daniel Sarewitz, co-director and co-founder of the Consortium for Science, Policy, and Outcomes at Arizona State University, made the important point in Nature (June 23) that weighing up the benefits and risks of gene editing and artificial intelligence is a political endeavour, not an academic one: “Science can’t solve it.”
Also in Nature (June 24), science and technology studies scholar Charis Thompson deplored the simplistically gendered nature of much of the discussion and urged a balanced approach aiming for “better science and better ethics.”
Republican members of the U.S.
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.